We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


StemLifeLine Introduces First Service Allowing IVF Patients to Develop Personal Stem Cell Lines

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "StemLifeLine Introduces First Service Allowing IVF Patients to Develop Personal Stem Cell Lines"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

StemLifeLine has announced that it received approval from the California Department of Health Services (CDHS) to engage in the operation of a tissue bank in accordance with Division 2, Chapter 4.1 of the Health and Safety Code.

With this Tissue Bank license, individuals who have undergone in vitro fertilization (IVF) may now use StemLifeLine's service to develop personal stem cell lines from their remaining stored embryos. StemLifeLine is the first life sciences company to offer this service through IVF centers.

"Developing a personal stem cell line is like buying insurance for the future," stated Ana Krtolica, Ph.D., cofounder, CEO and chief scientific officer (CSO) of StemLifeLine.

"Until now, there have been only three options for frozen embryos remaining from the in vitro fertilization process. They could be donated to research, given up for 'adoption' to other couples or discarded. With our approved California Tissue Bank license, we can now offer IVF patients the option to derive and preserve their own stem cell line for their future use," Krtolica added.